Deverra Therapeutics, Inc.

CIK 1822782 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Deverra Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
May 6, 2026C-AR0001822782-26-000003
Apr 10, 2025C-AR0001665160-25-000587
Sep 25, 2024C-U0001665160-24-001345
Jun 12, 2024C/A0001665160-24-000977
Apr 26, 2024C/A0001665160-24-000559
Apr 26, 2024C-AR0001665160-24-000561
Mar 28, 2024C0001665160-24-000283
Sep 18, 2023D0001822782-23-000003
Aug 27, 2020D0001822782-20-000002